WCG
IDXX icon

Weaver Consulting Group’s Idexx Laboratories IDXX Stock Holding History

Weaver Consulting Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23
Closed -$9K – 478
2020
Q3 		$9K Hold
23
– – 0.01% 579
2020
Q2 		$8K Hold
23
– – ﹤0.01% 571
2020
Q1 		$6K Hold
23
– – ﹤0.01% 530
2019
Q4 		$6K Hold
23
– – ﹤0.01% 573
2019
Q3 		$7K Hold
23
– – ﹤0.01% 530
2019
Q2 		$6K Hold
23
– – ﹤0.01% 539
2019
Q1 		$6K Buy
+23
New +$4.75K ﹤0.01% 1063

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Weaver Consulting Group's IDXX Position: Q4 2020 in Review

Weaver Consulting Group sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 23 shares — an estimated $9K sold.

Weaver Consulting Group first reported a position in IDXX in Q1 2019 and held it in 7 quarters. The position peaked at $9K in Q3 2020. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Weaver Consulting Group reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 23 Idexx Laboratories shares in Q4 2020, an estimated $9K.
  • Weaver Consulting Group first reported a position in Idexx Laboratories in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Idexx Laboratories position peaked at $9K in Q3 2020.
  • 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.